Answer
Entyvio (vedolizumab) 300 mg is administered as an intravenous infusion over 30 minutes, with patients monitored during and after infusion.
Sources for this answer
- Entyvio 300 mg powder for concentrate for solution for infusionTakeda UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 17Document updated
Sources checked